Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion type Assertion NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_head.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion description "[Although there is consensus on the cost-effectiveness of a universal approach of screening all colorectal cancer patients for Lynch syndrome (LS) using mismatch-repair (MMR) protein immunohistochemistry (IHC) and/or microsatellite instability (MSI) testing, the question of universal versus selective screening of endometrial cancer patients remains to be resolved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_provenance.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion evidence source_evidence_literature NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_provenance.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion SIO_000772 24503759 NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_provenance.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion wasDerivedFrom befree-2016 NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_provenance.
- NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_assertion wasGeneratedBy ECO_0000203 NP1152793.RADfNoBw5Wes6nYs_NSC9_czU2UQbn03CvgpWgSRILQNU130_provenance.